Immunology & Oncology

Research carried out in the Department of Immunology and Oncology (DIO) centres on characterizing the molecular and cellular bases of immune system function in inflammation and tumour development. Our general objective is to develop improved or new approaches for modulating the immune response during inflammatory reactions. We thus aim to identify new targets for prevention, diagnosis and treatment of inflammatory or autoimmune diseases and cancer.

Our common research objective provides an excellent environment and numerous opportunities for collaboration within the department as well as with other groups in the CNB (for example, the nanobiomedicine initiative). Since its origins, the DIO has maintained stable, productive collaborations with public and private partners that include prominent national and international research institutes, hospitals and pharmaceutical companies.

Head: Domingo F. Barber